1. Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer
    Ruisong Wang et al, 2022, Journal of Oncology CrossRef
  2. Wnt/β‐catenin signaling pathway participates in the effect of miR‐626 on oral squamous cell carcinoma by targeting RASSF4
    Sheng‐Hai Cui et al, 2021, Journal of Oral Pathology & Medicine CrossRef
  3. Myeloid cell leukemia-1 expression in cancers of the oral cavity: a scoping review
    Su-Jung Choi et al, 2022, Cancer Cell International CrossRef
  4. Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment
    Wenwen Wang et al, 2022, Computational and Structural Biotechnology Journal CrossRef
  5. The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis
    Letícia Martins Guimarães et al, 2021, Journal of Oral Pathology & Medicine CrossRef
  6. Peroxiredoxin 1 inhibits autophagy through interacting with Rab7 in human dysplastic oral keratinocyte cells
    Wenchao Wang et al, 2022, Archives of Oral Biology CrossRef
  7. A de novo variant in RERE causes autistic behavior by disrupting related genes and signaling pathway
    Qian Li et al, 2024, Clinical Genetics CrossRef
  8. Analysis of the relationship of somatic mutations with the development of leukoplakia and squamous cell carcinoma of the oral mucosa
    N. A. Karpuk et al, 2023, Proceedings of the National Academy of Sciences of Belarus, Medical series CrossRef
  9. Germline mutations in patients with oral mucosal leukoplakia and squamous cell carcinoma: a prospective observational study
    N. A. Karpuk et al, 2023, Kuban Scientific Medical Bulletin CrossRef
  10. Inhomogeneity of stiffness and density of the extracellular matrix within the leukoplakia of human oral mucosa as potential physicochemical factors leading to carcinogenesis
    Katarzyna Pogoda et al, 2021, Translational Oncology CrossRef
  11. Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia‑1
    Hyun-Ju Yu et al, 2023, International Journal of Molecular Medicine CrossRef